NyquistAI, formerly known as Nyquist Data, is making a strategic pivot that aligns with our evolution as a company and our commitment to the life sciences sector to help companies in life sciences embark on AI transformation within their organizations.
In the past year, we took a significant step by...
Ochre Bio, a pioneer in chronic liver disease medicine development, announced a partnership with Boehringer Ingelheim focused on the discovery and development of novel, first-in-class regenerative treatments for chronic liver diseases (CLDs), such as late-stage metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis.
Within the partnership, Ochre Bio will utilise its proprietary discovery...
Veracyte, Inc., a leading cancer diagnostics company, announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance (AS) for prostate cancer, the Decipher Prostate Genomic Classifier is prognostic for identifying those whose disease is likely to progress. The findings make the Decipher test...
Profluent, the AI-first protein design company, today debuted the OpenCRISPRTM initiative, releasing the world’s first open-source, AI-generated gene editor. With this launch, Profluent demonstrates the first successful precision editing of the human genome with customizable gene editors designed from scratch with AI.
OpenCRISPR-1 is an AI-created gene editor, consisting of a...
AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, recently announced that the company has signed supply agreements in Germany and the United Kingdom. Following these agreements, the company plans to accelerate its overseas market penetration and increase its presence in European markets.
In collaboration with its partner in...
A Significant Milestone Towards Aiding Rare Diseases Companies Leverage Cutting-Edge Technology and Consulting Expertise to Elevate Patient Care
CustomerInsights.AI is pleased to announce a global strategic go-to-market partnership with Ambit, a technology-enabled solutions company focused on rare and specialty diseases companies.
By combining ciPARTHENON™'s scalable, ready-to-deploy, Life Sciences-specific data architecture & models, automated...
This approval helps address an urgent unmet need, with about half of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant chemotherapy
Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved Alecensa® (alectinib) for adjuvant treatment following tumor resection for...
Veeva Systems announced Veeva Vault CRM Campaign Manager, a new industry-specific marketing application that simplifies and speeds non-personal promotion to healthcare professionals. Vault CRM Campaign Manager lives in the same Vault as Veeva Vault CRM and shares the same customer data, giving sales and marketing the effortless synchronization needed for true...
ProPhase Labs, Inc., a biopharma, genomics, and diagnostics Company, announced an innovative step forward in cancer treatment research with the introduction of Project ZenQ-AI. This project employs the Company’s state-of-the-art AI platform which was meticulously developed with leading AI technology platforms and systems. The Company is harnessing its extensive...
TetraScience, the Scientific Data and AI Cloud company, announced a strategic partnership with Google Cloud at the Bio-IT World Conference & Expo to speed up drug development and other scientific discoveries. By bringing the Tetra Scientific Data and AI Cloud together with Google Cloud’s infrastructure and AI technologies, the...
